For the quarter ended December 2025, Eastman Chemical (EMN) reported revenue of $1.97 billion, down 12.1% over the same period last year. EPS came in at $0.75, compared to $1.87 in the year-ago quarter.
The reported revenue represents a surprise of -3.15% over the Zacks Consensus Estimate of $2.04 billion. With the consensus EPS estimate being $0.76, the EPS surprise was -1.68%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Eastman Chemical performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Sales- Chemical Intermediates: $418 million compared to the $445.28 million average estimate based on four analysts. The reported number represents a change of -16.9% year over year.
- Net Sales- Fibers: $234 million versus the four-analyst average estimate of $244.64 million. The reported number represents a year-over-year change of -27.1%.
- Net Sales- Advanced Materials: $656 million versus $677.13 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -8.9% change.
- Net Sales- Additives & Functional Products: $662 million versus $668.41 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -4.9% change.
- Net Sales- Other: $3 million versus $5 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -40% change.
- Adjusted EBIT- Additives & Functional Products: $94 million compared to the $88.79 million average estimate based on four analysts.
- Adjusted EBIT- Advanced Materials: $59 million versus $46.76 million estimated by four analysts on average.
- Adjusted EBIT- Chemical Intermediates: $-28 million versus $-4.29 million estimated by four analysts on average.
- Adjusted EBIT- Other: $-40 million versus $-37.75 million estimated by four analysts on average.
- Adjusted EBIT- Fibers: $49 million versus $62.33 million estimated by four analysts on average.
View all Key Company Metrics for Eastman Chemical here>>>
Shares of Eastman Chemical have returned +8.2% over the past month versus the Zacks S&P 500 composite's +0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Eastman Chemical Company (EMN): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
